▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions via their national reporting system.
EU: Adverse events should be reported to Incyte immediately by phoning +800 000 27423 (or use local numbers listed on this website [https://www.incyte.com/contact-us/medical-information]) or via email at eumedinfo@incyte.com
UK: Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk. Adverse events should also be reported to Incyte immediately by phoning 0330 100 3677 (Great Britain) or 00 800 0002 7423 (United Kingdom [Northern Ireland])
EU/PEMA/P/21/0005
Date of preparation: November 2023
© 2023, Incyte Biosciences International Sarl. All rights reserved.
Marketing authorisation holder: Incyte Biosciences Distribution B.V.
PEMAZYRE, the PEMAZYRE logo and the Incyte logo are registered trademarks of Incyte
If you would like to request further medical information, please visit:
https://www.incyteglobalmedicalinformation.com/
Intended for licensed healthcare professionals located in the Europe.
You are now leaving the Incyte PEMAZYRE® website. This link will take you to a site that is not owned or maintained by Incyte. Incyte is not responsible for the information contained on third–party sites. Would you like to continue?